Aurora Cannabis Exec Says Company Well-Positioned In Germany, Will Push For Expansion Of Medical Market
Several weeks ago Germany became the third country in Europe to legalize adult-use marijuana after Malta and Luxembourg. Being the second most populous country on the continent with a population of about 84 million, the market potential is huge. Some experts predict the reform could lead to millions of medical marijuana patients, especially since under the approved law, marijuana can be prescribed as regular prescription medication, which creates significant benefits for medical marijuana patients. Taking all this into account it’s no wonder that soon after the Budenstag’s vote on Feb.23, marijuana stocks jumped. Several cannabis giants told Benzinga what this means for cannabis in Europe and shared their projections and expectations.
We also wanted to hear from one of the largest cannabis companies in the world, Aurora Cannabis (NASDAQ:ACB). Based in Canada, Aurora Cannabis serves people around the globe, with its operations spanning 25 countries across five continents. Its market cap is at $166.89 million. The company operates both medical and recreational cannabis as well as in the hemp-derived CBD sector. In recent years, its focus has been on the medical marijuana market in Europe. To learn more about its plans in Germany, Benzinga talked with Dirk Heitepriem, Aurora’s vice president of external …